Nokia Corporation
Stock Exchange Release
April 11, 2018 at 12:45 (CET +1)
Changes in Nokia Corporation's own shares
Espoo, Finland - A total of 7 113 Nokia shares (NOKIA) held by the company were today transferred without consideration to participants of Nokia's equity-based incentive plan as settlement in accordance with the plan rules. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to plan participants as announced on February 1, 2018.
The number of own shares held by Nokia Corporation following the transfer is 32 493 664.
About Nokia
We create the technology to connect the world. Powered by the research and innovation of Nokia Bell Labs, we serve communications service providers, governments, large enterprises and consumers, with the industry's most complete, end-to-end portfolio of products, services and licensing.
We adhere to the highest ethical business standards as we create technology with social purpose, quality and integrity. Nokia is enabling the infrastructure for 5G and the Internet of Things to transform the human experience. www.nokia.com
Media Inquiries:
Nokia
Communications
Tel. +358 (0) 10 448 4900
Email: [email protected]
Jon Peet, Vice President, Corporate Communications


Meta, U.S. States Discuss Settlement in Teen Addiction Trial
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
OpenAI AI Agent Swarm Behind Hugging Face Hack
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Amazon Secures 200 MW Wind Power Deals in Sweden
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Toyota Global Sales Fall as China Demand Slumps
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 



